Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

U.K. market introduction for Singulair

March 5, 1998

Distribution and marketing of terfenadine-containing products discontinued in U.S.

March 4, 1998

FDA okays labeling change for Pulmozyme

March 3, 1998

Neuropeptide Y Y2 agonists prepared at Peptech/CRC

March 3, 1998

Milestone reached in Genome Therapeutics/Schering-Plough alliance

Feb. 27, 1998

Fujisawa develops new inhibitors of NO production

Feb. 27, 1998

Ariflo possesses potent antiinflammatory activity, without GI side effects

Feb. 26, 1998

T-440: a new antiasthma drug candidate from Tanabe

Feb. 26, 1998

Animal study indicates efficacy of oral PAF antagonist in allergic rhinitis

Feb. 26, 1998

TRH ineffective as treatment for lung problems in premature infants

Feb. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026